Investor Overview

Company Profile

Vitae Pharmaceuticals is a clinical stage biotechnology company focused on discovering and developing novel, small molecule drugs for diseases with significant unmet medical need. We are developing a robust and growing portfolio of novel product candidates generated by Contour®, our proprietary structure-based drug discovery platform.... More >>

Recent News

More >>
DateTitle  
09/14/16Allergan to Acquire Vitae Pharmaceuticals Adding Innovative Development Programs for Dermatologic Conditions Download PDFPrinter Friendly Version
09/01/16Vitae Pharmaceuticals to Present at Wells Fargo Healthcare ConferenceDownload PDFPrinter Friendly Version
08/11/16Vitae Pharmaceuticals to Present at Wedbush PacGrow Healthcare ConferenceDownload PDFPrinter Friendly Version
08/10/16Vitae Pharmaceuticals Appoints Scott Applebaum as General Counsel and Corporate SecretaryDownload PDFPrinter Friendly Version

Upcoming Events

More >>
There are currently no events scheduled.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.